Dr Nigel Brown Email & Phone Number

Princeton, Nj, Us

Ewing, New Jersey, Us

Universal Display Corporation (NASDAQ: OLED) is lighting up the organic light emitting diode (OLED) revolution with its proprietary OLED technologies and proprietary phosphorescent materials. The Company is a world-class IP innovator, technology developer, patent licensor and materials supplier for the rapidly growing OLED markets. We are a leader in developing and delivering state-of-the-art, OLED technologies, materials and services to the display and lighting industries.

Paris, France, Fr

West Lafayette, In, Us

At Inotiv (NASDAQ: NOTV), our focus is clinical decision support for development of new medicines: We deliver a comprehensive and integrated range of preclinical safety assessment services, analysis, bioanalysis, and DMPK and consulting solutions essential to drug development success.

Birmingham, Al, Us

Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics. Our mission is to simplify the delivery of molecular technologies. We do this by developing, producing, and supplying multiplex assays for research use. We believe individualized molecular data is the foundation for understanding and diagnosing many diseases.

Birmingham, Alabama, Us

Molecular insights are often the deciding factor for patient management. Our solutions empower researchers and physicians with the best data, faster and more efficiently. Whether you need to equip and optimize an existing lab or establish a new lab, Streamline Scientific equips healthcare providers and researchers with solutions that lower cost, yield faster, more accurate insights—driving better-informed research and treatment decisions.

Founder of Princeton Healthcare Advisory LLC, a specialty advisory firm supporting growth-focused private equity, venture capital and strategic investors in the healthcare and life sciences sectors.

Montreal, Qc, Ca

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is a cardiovascular drug development company developing novel small molecule therapeutics based on clinically validated mechanisms. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as supraventricular tachycardia.

LifeBlood is a privately held company dedicated to the introduction of a revolutionary and proprietary diagnostic test for the early detection of multiple sclerosis.

Chuo-Ku, Tokyo, Jp

Vorpal was sold to IQVIA in 2024.Vorpal offers expertise in market assessment, clinical, regulatory and reimbursement services for medical device companies, enabling their successful entry into Japan.

Washington, Dc, Us

MCRA was sold to IQVIA in 2024.MCRA’s mission is to be the leading strategic advisory services firm and clinical research organization to the life sciences industry by collaborating, supporting, and providing integrated services to balance value creation with risk mitigation to achieve pre-commercial and post-commercial success for the total product lifecycle.

New York, Ny, Us

Arsenal is a specialized private equity firm with what it believes are market-leading franchises in the industrials and healthcare sectors. The firm’s mission is to build high-growth, technology- and innovation-rich businesses that are strategically important in their markets and deliver value for all stakeholders.

Trevi Health Capital is a specialist investment firm that provides healthcare-focused alternative asset management through a variety of private equity funds on a global scale. We were founded in 2005 and have invested over $500 million in the healthcare sector. We provide private equity capital for growth stage and middle-market healthcare companies with emphasis on healthcare information technology, healthcare services and medical technology. The investment team combines experienced investment professionals and senior-level executives and entrepreneurs with proven track records in the healthcare sector.

London, Gb

Drug Discovery World is the multi-platform global voice for the drug discovery community. From research stage to clinical trials the brand covers the scientific and commercial process involved in getting a drug to market–research, target identification and validation, drug molecule identification, lead molecule optimisation, pre-clinical research, clinical trial authorisation and application, and clinical trials phase I and II. DDW readers learn how to turn science into business.

Cambridge, Ma, Us

Served as Chairmen and Board Member leading up to the successful out-licensing of the company’s lead asset, BA-210 for spinal cord injury, to Vertex Pharmaceutics (NASDAQ: VRTX) in 2015, and successful out-licensing of additional assets to Neurelis in 2020 for treatment of Cerebral Cavernous Malformation.BioAxone is a private biotechnology company focused on the development of innovative drugs to restore neurological function and improve quality of life after spinal cord injury and other forms of neurotrauma. Our lead product, Cethrin™, is a proprietary biologic drug designed to reduce paralysis after spinal cord injury. Phase I/IIa clinical results show that Cethrin holds promise for promoting meaningful recovery after spinal cord injury and safely advancing the road to repair.

New York, Ny, Us

Health Catalyst Capital Management is a venture capital fund investing in high growth US- based Healthcare IT businesses focused in a few key themes, each with potential to achieve $1 billion enterprise value in new or disrupted markets globally

Indianapolis, Indiana, Us

Strategic Advisor to Envigo leading up to the successful sale of its Preclinical Services division to LabCorp (NYSE: LH) in 2019.Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world.

CytoVas, LLC is a clinical stage, in-vitro diagnostics (IVD) company developing advanced cell- and particle-based assays for evaluating cardiovascular health. Our products leverage proprietary sample preparation, high-content, ultra-sensitive flow cytometry and biocomputation to yield a signature fingerprint of a patient’s vascular health status. Our technology addresses a broad range of applications, including drug development, to assess cardiovascular efficacy and liabilities across all therapeutic drug classes, clinical trial design, to target optimal responders, limit adverse events and monitor cardiovascular responses to drug therapy, and companion diagnostics and for clinical diagnostics to facilitate cardiovascular risk stratification and treatment/prevention decision-making.

San Mateo, Ca, Us

Strategic Advisor to Vium, which was successfully sold to Recursion Pharma (NASDAQ: RXRX) in 2020. Vium is the leader in living informatics platforms, focused on applying advances in life sciences, digital technology and large-scale interpretive methods to living systems. Vium combines the latest in sensors, computer intelligence and biomedical science to help researchers get higher quality, more predictive data from preclinical studies.

Hamilton, New Jersey, Us

Board Member and investor at MedAvante, leading up to its sale to WCG.MedAvante is the leading global provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders with more than a decade of experience improving clinician-reported diagnostic and outcome measurements.

Princeton, New Jersey, Us

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $2 billion, global operations in more than 30 countries, and more than 12,000 employees worldwide. Covance provides high-quality nonclinical, clinical, and commercialization services to pharmaceutical and biotechnology companies to help reduce the time and costs associated with drug development. We also offer laboratory testing services to the chemical, agrochemical and food industries and are a market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services.

King Of Prussia, Pennsylvania, Us

MDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions. We offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities.

SVP & GM at Phoenix International leading up to its sale to MDS Inc. in 2000.Phoenix International Life Sciences Inc. is one of the world's leading contract research organizations. The Company provides a wide spectrum of clinical, analytical, preclinical, drug discovery support and ancillary services to the pharmaceutical and biotechnology industries. Headquartered in Montreal, Quebec, the Company has operations throughout Europe and North America and research facilities in Australia, Israel and South Africa.

Algene Biotechnologies Corporation is active in the field of biomedical genetics as applied to the treatment of human diseases. Research and development activities focus on genes that cause Alzheimer disease, schizophrenia, migraine and Parkinson disease.

Brentford, Middlesex, Gb

GSK is a science-led global healthcare company with a mission to help people do more, feel better, and live longer. Our goal is to be one of the world’s more innovative, best performing and most trusted healthcare companies. GSK has three global businesses that research, develop, and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products.

New York, New York, Us

Pfizer is an evolving company in a changing world. We've grown, in our 173 years, from a small family-owned business to a research-based pharmaceutical company that is now the world's largest and most valuable company devoted to healthcare.Our mission is to become the world's most valued company to patients, customers, colleagues, investors, business partners and the communities where we work and live.

B.A.(Hons), Chemistry With Chemical Pharmacology

Doctor Of Philosophy - D.Phil., Physiological Sciences (Metabolism And Pharmacology)

Nestlé Post-Doctoral Fellowship, Toxicology

M.B.A., Business Administration